H. Shi

Chinese medicine (Q-14) in the Treatment of Patients with Coronavirus Disease 2019 (COVID-19): A Single-center, Open label, Randomised Controlled Trial

L. Leng, L. Guo, J. Li, 2021, medRxiv.